Cart
sales@molnova.com
Protein kinase inhibitor H-7
CAS No. 84477-87-2
Protein kinase inhibitor H-7( -(5-Isoquinolinylsulfonyl)-2-methylpiperazine | 5-(2-methylpiperazine-1-sulfonyl)isoquinoline )
Catalog No. M28552 CAS No. 84477-87-2
Protein kinase inhibitor H-7 is a potent inhibitor of protein kinase C (PKC) with a Ki of 6 μM. Protein kinase inhibitor H-7 is also a cyclic nucleotide dependent protein kinase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 78 | Get Quote |
|
| 25MG | 123 | Get Quote |
|
| 50MG | 176 | Get Quote |
|
| 100MG | 257 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameProtein kinase inhibitor H-7
-
NoteResearch use only, not for human use.
-
Brief DescriptionProtein kinase inhibitor H-7 is a potent inhibitor of protein kinase C (PKC) with a Ki of 6 μM. Protein kinase inhibitor H-7 is also a cyclic nucleotide dependent protein kinase inhibitor.
-
DescriptionProtein kinase inhibitor H-7 is a potent inhibitor of protein kinase C (PKC) with a Ki of 6 μM. Protein kinase inhibitor H-7 is also a cyclic nucleotide dependent protein kinase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms-(5-Isoquinolinylsulfonyl)-2-methylpiperazine | 5-(2-methylpiperazine-1-sulfonyl)isoquinoline
-
PathwayAngiogenesis
-
TargetPKC
-
RecptorSmoothened
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number84477-87-2
-
Formula Weight291.37
-
Molecular FormulaC14H17N3O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (343.21 mM)
-
SMILESO=S(=O)(C1=CC=CC=2C=NC=CC21)N3CCNCC3C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang Y, et al. Selective identification of hedgehog pathway antagonists by direct analysis of smoothened ciliary translocation. ACS Chem Biol. 2012 Jun 15;7(6):1040-8.
molnova catalog
related products
-
Roy-Bz
Roy-Bz is the?first?small-molecule?PKCδ-selective activator with EC50 of 58.5 nM, binds to the PKCδ-C1-domain.
-
Valrubicin
Valrubicin (AD 32) inhibits TPA- and PDBu-induced PKC activation (IC50s: 0.85 and 1.25 μM) and has antitumor and anti-inflammatory activity.
-
Go 6976
A potent, selective protein kinase C (PKC) inhibitor that selectively inhibits PKCα and PKCβ1 with IC50 of 2.3 and 6.2 nM, respectively.
